Increased Galactosidase Beta 1 Expression as a Senescent Key Factor in β-Cells Function Modulation at the Early Steps of Type 2 Diabetes

Abstract

Background In type 2 diabetes, insulin resistance is observed, and β-cells are incapable of responding to glycemia demands, leading to hyperglycemia. Although the nature of β-cells dysfunction in this disease is not fully understood, a link between the induction of pancreatic β-cell premature senescence and its metabolic implications has been proposed. This study aimed to understand the relationship between diabetes and pancreatic senescence, particularly at the beginning of the disease.

Methods C57Bl/6 J mice were fed two different diets, a normal diet and a high-fat diet, for 16 weeks. Pancreatic histomorphology analysis, insulin quantification, inflammation parameters, and senescence biomarkers for the experimental animals were assessed at weeks 12 and 16.

Results The results proved that diabetes onset occurred at week 16 in the High Fat Diet group, supported by glycaemia, weight and blood lipid levels. Increased β-cells size and number accompanied by increased insulin expression were observed. Also, an inflammatory status of the diabetic group was noted by increased levels of systemic IL-1β and increased pancreatic fibrosis. Finally, the expression of galactosidase-beta 1 (GLB1) was significantly increased in pancreatic β-cells.

Conclusion The study findings indicate that senescence, as revealed by an increase in GLB1 expression, is a key factor in the initial stage of diabetes.

Key words

Diabetes- pancreatic cells, cellular senescence, histomorphology, markers

Publication History

Received: 26 November 2022
Received: 11 February 2023

Accepted: 16 February 2023

Article published online:
18 April 2023

• References

• 1 Watanabe T, Yonemurat Y, Yonekura H. et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Med Sci 1994; 91: 3589-3592
• 2 Gross DJ, Weiss L, Reibstein I. et al. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 1998; 139: 2369-2374
• 3 Merino PLH. Developmental biology of the pancreas. Cell Biochem Biophys 2004; 40: 127-142
• 4 Must A, Spadano J, Coakley EH. et al. The disease burden associated with overweight and obesity. J Am Med Assoc 1999; 282: 1523-1529
• 5 Kasuga M. Insulin resistance and pancreatic β cell failure. J Clin Invest 2006; 116: 1756-1760
• 6 Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846
• 7 Kulkarni RRNRRN, Brüning JCJJC, Winnay JJNJ. et al. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell-Cambridge Ma- 1999; 96: 329-339
• 8 Rebours V, Garteiser P, Ribeiro-Parenti L. et al. Obesity-induced pancreatopathy in rats is reversible after bariatric surgery. Sci Rep 2018; 8: 1-11
• 9 Olivieri F, Prattichizzo F, Grillari J. et al. Cellular senescence and inflammaging in age-related diseases. Mediators Inflamm 2018; 2018: 1-6
• 10 Davalli P, Mitic T, Caporali A. et al. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev 2016; 2016: 1-18
• 11 Maduro AT, Luís C, Soares R. Ageing, cellular senescence and the impact of diet: An overview. Porto Biomed J 2021; 6: e120
• 12 Bennett GC, Matej D, Darren JB. et al. Cellular senescence in aging and age-related disease: From mechanisms to therapy Bennett. Nat Med 2015; 21: 1424-1435
• 13 Dimri GP, Leet X, Basile G. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Natl Acad Sci United States Am 1995; 92: 9363-9367
• 14 Sone H, Kagawa Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 2005; 48: 58-67
• 15 Helman A, Klochendler A, Azazmeh N. et al. p16 Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion. Nat Med 2016; 22: 412-420
• 16 Cardiff RD, Miller CH, Munn RJ. et al. Manual hematoxylin and eosin staining of mouse tissue sections manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014; 655-658
• 17 Kiernan JA. Sirius red staining protocol for collagen. MedEmoryEdu 2013; 1-3
• 18 Lee BY, Han JA, Im JS. et al. Senescence-associated β-galactosidase is lysosomal β-galactosidase. Aging Cell 2006; 5: 187-195
• 19 Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne) 2013; 4: 1-12
• 20 Parisi L, Gini E, Baci D. et al. Review article macrophage polarization in chronic inflammatory diseases: Killers or builders?. J Immunol Researc 2018; 2018: 1-25
• 21 Salama R, Sadaie M, Hoare M. et al. Cellular senescence and its effector programs. Genes Dev 2014; 28: 99-114
• 22 Paradis V, Youssef N, Dargère D. et al. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 2001; 32: 327-332
• 23 Price JS, Waters JG, Darrah C. et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002; 1: 57-65
• 24 Russell WM, Burch R. Principle of Human Experimental Techniques. John Hopkins Bloomberg School of Public Health 1959; 1-229
• 25 Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 2016; 37: 278-316